Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis.

Combe B, Rahman P, Kameda H, Cañete JD, Gallo G, Agada N, Xu W, Genovese MC

Open source

DOI
10.1186/s13075-020-2099-0
Published
2020 Jan 21
Container
Arthritis research & therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13075-020-2099-0,
  title = {Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis.},
  author = {Combe B and Rahman P and Kameda H and Cañete JD and Gallo G and Agada N and Xu W and Genovese MC},
  year = {2020},
  journal = {Arthritis research \& therapy},
  doi = {10.1186/s13075-020-2099-0},
  url = {https://doi.org/10.1186/s13075-020-2099-0}
}

RIS

TY  - JOUR
TI  - Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis.
AU  - Combe B
AU  - Rahman P
AU  - Kameda H
AU  - Cañete JD
AU  - Gallo G
AU  - Agada N
AU  - Xu W
AU  - Genovese MC
PY  - 2020
JO  - Arthritis research & therapy
DO  - 10.1186/s13075-020-2099-0
UR  - https://doi.org/10.1186/s13075-020-2099-0
ER  - 

APA

B, C., P, R., H, K., JD, C., G, G., N, A., W, X., & MC, G. (2020). Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis.. Arthritis research & therapy. https://doi.org/10.1186/s13075-020-2099-0

Source records